Modulation of a 40-kDa catecholamine-regulated protein following d-amphetamine treatment in discrete brain regions

By Gabriele J.   Rajaram M.   Zhang B.   Sharma S.   Mishra R.K.  

European Journal of Pharmacology, Vol. 453, Iss. 1, 2002-10 ,pp. : 13-19

Elsevier

Access to resources Recommend Favorite

Patented biological approaches for the therapeutic modulation of the 37 kDa/67 kDa laminin receptor

By Omar Aadilah   Jovanovic Katarina   Da Costa Dias Bianca   Gonsalves Danielle   Moodley Kiashanee   Caveney Robert   Mbazima Vusi   Weiss Stefan FT  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 1, 2011-01 ,pp. : 35-53

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of a Porphyromonas gingivalis Colonizing Factor between Actinomyces viscosus ATCC 19246 by Monoclonal Antibodies against Recombinant 40-kDa Outer-Membrane Protein

By Saito S.   Hiratsuka K.   Hayakawa M.   Takiguchi H.   Abiko Y.  

General Pharmacology, Vol. 28, Iss. 5, 1997-05 ,pp. : 675-680

Elsevier

Access to resources Recommend Favorite

Peginterferon-α_2a (40 kDa) for chronic hepatitis C

By Hadziyannis Stephanos J   Papatheodoridis George V  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 4, 2003-04 ,pp. : 541-551

Informa Healthcare

Access to resources Recommend Favorite

Modulation of amphetamine-stimulated (transporter mediated) dopamine release in vitro by 2 receptor agonists and antagonists

By Izenwasser S.   Thompson-Montgomery D.   Deben S.E.   Chowdhury I.N.   Werling L.L.  

European Journal of Pharmacology, Vol. 346, Iss. 2, 1998-04 ,pp. : 189-196

Elsevier

Access to resources Recommend Favorite